ZIM
KYNB

Zacks Investment Management’s Kyntra Bio KYNB Stock Holding History

Zacks Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-644
Closed -$597K – 529
2020
Q4 		$597K Sell
644
-50
-7% -$52.6K 0.01% 400
2020
Q3 		$713K Sell
694
-37
-5% -$39.8K 0.01% 359
2020
Q2 		$741K Sell
731
-142
-16% -$132K 0.02% 351
2020
Q1 		$759K Sell
873
-413
-32% -$411K 0.02% 339
2019
Q4 		$1.38M Buy
1,286
+348
+37% +$355K 0.03% 338
2019
Q3 		$867K Sell
938
-128
-12% -$141K 0.02% 389
2019
Q2 		$1.2M Buy
1,066
+30
+3% +$32.8K 0.02% 371
2019
Q1 		$1.41M Buy
1,036
+33
+3% +$44.8K 0.03% 324
2018
Q4 		$1.16M Buy
+1,003
New +$1.13M 0.03% 322
2018
Q2 		– Sell
-426
Closed -$492K – 565
2018
Q1 		$492K Sell
426
-11
-3% -$14.5K 0.01% 459
2017
Q4 		$518K Buy
437
+113
+35% +$142K 0.01% 467
2017
Q3 		$436K Hold
324
– – 0.01% 459
2017
Q2 		$262K Sell
324
-290
-47% -$202K 0.01% 506
2017
Q1 		$378K Buy
+614
New +$374K 0.01% 478

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Zacks Investment Management's KYNB Position: Q1 2021 in Review

Zacks Investment Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 644 shares — an estimated $597K sold.

Zacks Investment Management first reported a position in KYNB in Q1 2017 and held it in 14 quarters. The position peaked at $1.41M in Q1 2019. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Zacks Investment Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Zacks Investment Management sold 644 Kyntra Bio shares in Q1 2021, an estimated $597K.
  • Zacks Investment Management first reported a position in Kyntra Bio in Q1 2017 and held it in 14 quarters.
  • Zacks Investment Management's Kyntra Bio position peaked at $1.41M in Q1 2019.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Zacks Investment Management's 13F filing for Q1 2021, filed 17 May 2021.